Dr. Jeeseon Park-saltzman, PH.D. Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 4929 Dierker Rd Ste A, Upper Arlington, OH 43220 Phone: 614-929-5170 Fax: 614-929-5180 |
Meleesa A. Hunt, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 3070 Riverside Dr, Suite 150-b, Upper Arlington, OH 43221 Phone: 614-738-8878 |
Dr. James R. Harris, PH.D. Psychologist - Clinical Child & Adolescent Medicare: Not Enrolled in Medicare Practice Location: 1456 London Dr, Upper Arlington, OH 43221 Phone: 614-457-0566 |
Dr. J Robert Padberg, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 1570 Fishinger Rd, Upper Arlington, OH 43221 Phone: 614-451-2771 Fax: 614-451-4117 |
Dr. Helen Marie (davis) Rodebaugh, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2066 Henderson Rd, Suite 101, Upper Arlington, OH 43220 Phone: 614-752-0333 |
News Archive
Funds for new Medicare experiments - appropriated as part of the health law - may require special scrutiny to ensure they are spent correctly, a Medicare official said, CongressDaily/NextGov reports.
A new study led by scientists at The Scripps Research Institute identifies new immune molecules that protect against deadly Marburg virus, a relative of Ebola virus. The research provides ingredients needed to develop treatments for future Marburg outbreaks.
Research at Oregon State University has found that one particular omega-3 fatty acid has a powerful effect in preventing liver inflammation and fibrosis - common problems that are steadily rising along with the number of Americans who are overweight.
Thomas Toland, CEO of SGLN and SurgLine, Inc. announced today it has signed an agreement with MedNPV, LLC, a well-established management company and surgical group operator with business throughout the state of California. The agreement between the parties will permit SurgLine to supply its' low cost spinal orthopedic implants.
The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of ACTG 5395, a clinical trial to evaluate whether the drug combination hydroxychloroquine and azithromycin can prevent hospitalization and death from COVID-19 (which is caused by infection with the virus SARS-CoV-2).
› Verified 9 days ago